4 and 8.3%, respectively (OR,0.11; 95% CI, 0.02-0.60; P = 0.016). There was 12-month OS and 24-month PFS advantage with simultaneously taking CCBs and erlotinib, they have an additive effect for NSCLC. This study will be inspiring future prospective studies.Advanced breast cancer (ABC) is incurable. Previous studies have shown that vascular end…[Read more]

d for further physician and public education on allergies and antibiotic selection.Introduction Melanoma incidence rates are rising faster than the rates of any other malignancy. Olprinone clinical trial As a major global public health concern, melanoma can be identified by a visual exam not requiring expensive invasive procedures. However,…[Read more]

To examine the reproducibility of spectral domain optical coherence tomography (SD-OCT) segmented ganglion cell complex and circumpapillary retinal nerve fiber layer (cpRNFL) measurements in children with primary congenital glaucoma (PCG) in comparison with healthy children.

12 children with PCG (G1) and 24 healthy children (G2) were…[Read more]

To determine factors affecting mortality, and long-term patency of portal vein, in patients with pancreatic-portal vein fistula (PPVF).

Consecutive cases of PPVF at the University of Pittsburgh Medical Center from 2008 to 2020 were retrospectively identified. Clinical history, imaging studies, management strategies, complications, and…[Read more]